Sign in

CIK 0001640266 · Accelerated filer<br>Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-09 PFREUNDSCHUH PETER P. Chief Financial Officer Grant or award +30,000 179,433
2024-02-09 PFREUNDSCHUH PETER P. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +60,000 60,000
2024-01-17 Swartz Robin Chief Operating Officer Sale −2,543 $7.15 $18K 72,327
2024-01-17 Carter Todd Alfred Chief Scientific Officer Sale −1,266 $7.18 $9K 53,094
2023-10-03 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −13,567 $6.99 $95K 149,433
2023-10-01 Fahey Sandell Jacquelyn Chief Legal Officer Grant or award +61,000 61,000
2023-09-15 Carter Todd Alfred Chief Scientific Officer Option exercise 10b5-1 +5,000 $2.85 $14K 64,860
2023-09-15 Carter Todd Alfred Chief Scientific Officer Sale 10b5-1 −10,500 $8.16 $86K 54,360
2023-09-15 Carter Todd Alfred Chief Scientific Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 40,000
2023-07-10 Fahey Sandell Jacquelyn Chief Legal Officer Grant or award · Stock Option (Right to Buy) +122,000 122,000
2023-07-06 Carter Todd Alfred Chief Scientific Officer Sale 10b5-1 −5,500 $10.80 $59K 59,860
2023-06-30 Carter Todd Alfred Chief Scientific Officer Option exercise 10b5-1 +5,000 $2.85 $14K 70,360
2023-06-30 Carter Todd Alfred Chief Scientific Officer Sale 10b5-1 −5,000 $11.41 $57K 65,360
2023-06-30 Carter Todd Alfred Chief Scientific Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 45,000
2023-06-06 PIERCE GLENN Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-06-06 MACKEY CATHERINE J Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-06-06 Vitale Nancy Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-06-06 Onyia Jude Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-06-06 Higgins Michael J Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-06-06 Colon Grace Director Grant or award · Stock Option (Right to Buy) +22,000 22,000

Page 6 of 7 · 130 trades